| Literature DB >> 31011686 |
Wei Jiang1, Pranav Lakshminarayanan2, Xuan Hui3, Peijin Han3, Zhi Cheng3, Michael Bowers3, Ilya Shpitser4, Sauleh Siddiqui1, Russell H Taylor4, Harry Quon3, Todd McNutt3.
Abstract
PURPOSE: Patients with head-and-neck cancer (HNC) may experience xerostomia after radiation therapy (RT), which leads to compromised quality of life. The purpose of this study is to explore how the spatial pattern of radiation dose (radiomorphology) in the major salivary glands influences xerostomia in patients with HNC. METHODS AND MATERIALS: A data-driven approach using spatially explicit dosimetric predictors, voxel dose (ie, actual radiation dose in voxels in parotid glands [PG] and submandibular glands [SMG]) was used to predict whether patients would develop xerostomia 3 months after RT. Using planned radiation dose data and other nondose covariates including baseline xerostomia grade of 427 patients with HNC in our database, the machine learning methods were used to investigate the influence of dose patterns across subvolumes in PG and SMG on xerostomia.Entities:
Year: 2018 PMID: 31011686 PMCID: PMC6460328 DOI: 10.1016/j.adro.2018.11.008
Source DB: PubMed Journal: Adv Radiat Oncol ISSN: 2452-1094
Figure 1Distribution of radiation dose in parotid and submandibular glands across the patient cohort. (A) Mean voxel dose, (B) standard deviation of voxel dose, and (C) mean dose of patients who developed xerostomia, minus the mean dose of patients who did not.
Patient characteristics at baseline
| Predictor | Xerostomia grade ≥2 at 3 mo postradiation therapy | ||
|---|---|---|---|
| No (N = 282) | Yes (N = 145) | ||
| Age | 58.62 (52-67) | 58.47 (53-64) | .77 |
| Sex | .61 | ||
| Male | 210 (74.47%) | 112 (77.24%) | |
| Female | 72 (25.53%) | 33 (22.76%) | |
| Race | .24 | ||
| Caucasian | 196 (69.50%) | 113 (77.93%) | |
| African American | 65 (23.05%) | 22 (15.17%) | |
| Asian/Pacific islander | 8 (2.83%) | 7 (4.83%) | |
| Other | 13 (4.61%) | 3 (2.07%) | |
| Attending physician | .22 | ||
| 1 | 143 (50.71%) | 69 (47.59%) | |
| 2 | 58 (20.57%) | 28 (19.31%) | |
| 3 | 35 (12.41%) | 25 (17.24%) | |
| 4 | 3 (1.06%) | 3 (2.06%) | |
| Missing | 43 (15.25%) | 20 (7.09%) | |
| Chemotherapy | < .01 | ||
| Yes | 198 (70.21%) | 123 (84.83%) | |
| No | 84 (29.79%) | 22 (15.17%) | |
| Human papillomavirus | < .01 | ||
| Positive | 185 (65.60%) | 74 (51.03%) | |
| Negative | 94 (33.33%) | 71 (48.97%) | |
| Missing | 3 (1.06%) | 0 (0%) | |
| Feeding tube used | .06 | ||
| Yes | 196 (69.50%) | 88 (60.69%) | |
| No | 83 (29.43%) | 57 (39.31%) | |
| Missing | 3 (1.06%) | 0 (0%) | |
| Baseline xerostomia grade | < .01 | ||
| 0 | 216 (76.60%) | 99 (68.28%) | |
| 1 | 63 (22.34%) | 33 (22.76%) | |
| 2 | 3 (1.06%) | 13 (8.97%) | |
| Primary tumor stage (T stage) | .89 | ||
| 0 | 12 (4.26%) | 6 (4.13%) | |
| 1 | 50 (17.73%) | 29 (20.00%) | |
| 2 | 66 (23.40%) | 44 (30.34%) | |
| 3 | 47 (16.67%) | 23 (15.86%) | |
| 4 | 65 (23.05%) | 35 (24.14%) | |
| Missing | 42 (14.89%) | 8 (2.84%) | |
| Regional lymph nodes stage (N stage) | .11 | ||
| 0 | 69 (24.47%) | 25 (17.24%) | |
| 1 | 33 (11.70%) | 25 (17.24%) | |
| 2 | 128 (45.39%) | 83 (57.24%) | |
| 3 | 6 (2.13%) | 5 (3.45%) | |
| Missing | 46 (16.31%) | 7 (2.48%) | |
| Distant metastasis stage (M stage) | .51 | ||
| Yes | 16 (5.67%) | 6 (4.14%) | |
| No | 229 (81.21%) | 132 (91.03%) | |
| Missing | 37 (13.12%) | 7 (2.48%) | |
| Tumor site | < .01 | ||
| Oral cavity | 52 (18.44%) | 45 (31.03%) | |
| Oropharynx | 54 (19.15%) | 42 (28.97%) | |
| Nasopharynx | 12 (4.26%) | 14 (9.66%) | |
| Larynx | 54 (19.15%) | 17 (11.72%) | |
| Other | 110 (39.01%) | 27 (18.62%) | |
| Treatment side | < .01 | ||
| Unilateral | 8 (2.84%) | 3 (2.07%) | |
| Bilateral | 238 (84.40%) | 139 (96.55%) | |
| Lower in the neck | 36 (12.77%) | 2 (1.38%) | |
P-value obtained using the 2-sample test.
Summary statistics include the mean and interquartile range for continuous variables and the count and percentage value for categorical variables.
Figure 2Flowchart of key steps for this analysis. Abbreviations: ROI = region of interest.
Figure 3Distribution of xerostomia grade at baseline and 3 months after radiation therapy.
Figure 4Voxel importance patterns learned from the 3 machine learning algorithms where the color corresponds to the relative importance of each voxel.
Figure 5(A) Voxel importance pattern from ridge logistic regression and (B) different visualization of the same voxel importance result where voxel importance values that are 1 standard deviation (SD) away from the mean were saturated to increase the resolution of voxel importance closer to the mean value of the voxel importance. The saturated plot was created as the set of voxel importance values that are greater than 1 SD of the mean voxel importance values to be 1 SD of the voxel importance values plus the mean value. As a result, the voxels of which the voxel importance value is greater than 1 SD of the mean voxel importance values are shown in red. Similarly, voxels of which the voxel importance value is greater than 1 SD of the mean voxel importance values are shown in blue. Voxel importance values within 1 SD of the mean value is color coded from blue to red.
Figure 6Two-dimensional cross-sectional images from computed tomography scans of the reference patient, displaying the spatial location of the influential area and colored distribution of voxel-based dose feature importance. (A) Axial view of voxel importance pattern, (B) sagittal view of the voxel importance pattern on the contralateral side, (C) coronal view of the voxel importance pattern, and (D) sagittal view of the voxel importance pattern on the ipsilateral side.